FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912999289> ?p ?o ?g. }

• W2912999289 endingPage "1212" @default.
• W2912999289 startingPage "1193" @default.
• W2912999289 abstract "Ticagrelor (TCG) is used to inhibit platelet aggregation in patients with acute coronary syndrome, but its poor solubility and low bioavailability limit its in vivo efficacy. The purpose of this study was to manufacture an optimized TCG-loaded self-microemulsifying drug delivery system (SMEDDS) to enhance the oral bioavailability and antiplatelet activity of TCG.Solubility and emulsification tests were conducted to determine the most suitable oils, surfactants, and cosurfactants. Scheffé's mixture design was applied to optimize the percentage of each component applied in the SMEDDS formulation to achieve optimal physical characteristics, ie, high solubility of TCG in SMEDDS, small droplet size, low precipitation, and high transmittance.The optimized TCG-loaded SMEDDS (TCG-SM) formulation composed of 10.0% Capmul MCM (oil), 53.8% Cremophor EL (surfactant), and 36.2% Transcutol P (cosurfactant) significantly improving the dissolution of TCG in various media compared with TCG in Brilinta® (commercial product). TCG-SM exhibited higher cellular uptake and permeability in Caco-2 cells than raw TCG suspension. In pharmacokinetic studies in rats, TCG-SM exhibited higher oral bioavailability with 5.7 and 6.4 times higher area under the concentration-time curve and maximum plasma concentration, respectively, than a raw TCG suspension. Antiplatelet activity studies exhibited that the TCG-SM formulation showed significantly improved inhibition of platelet aggregation compared with raw TCG at the same dose of TCG. And, a 10 mg/kg dose of raw TCG suspension and a 5 mg/kg dose of TCG-SM had a similar area under the inhibitory curve (907.0%±408.8% and 907.8%±200.5%⋅hours, respectively) for antiplatelet activity.These results suggest that the developed TCG-SM could be successfully used as an efficient method to achieve the enhanced antiplatelet activity and bioavailability of TCG." @default.
• W2912999289 created "2019-02-21" @default.
• W2912999289 creator A5015663142 @default.
• W2912999289 creator A5031352775 @default.
• W2912999289 creator A5032300944 @default.
• W2912999289 creator A5059080514 @default.
• W2912999289 creator A5061082958 @default.
• W2912999289 creator A5061389332 @default.
• W2912999289 creator A5062026697 @default.
• W2912999289 creator A5062291767 @default.
• W2912999289 creator A5062825151 @default.
• W2912999289 creator A5063486241 @default.
• W2912999289 creator A5079206958 @default.
• W2912999289 date "2019-02-01" @default.
• W2912999289 modified "2023-09-25" @default.
• W2912999289 title "<p>Strategic approach to developing a self-microemulsifying drug delivery system to enhance antiplatelet activity and bioavailability of ticagrelor</p>" @default.
• W2912999289 cites W1625414941 @default.
• W2912999289 cites W1628091270 @default.
• W2912999289 cites W1964094153 @default.
• W2912999289 cites W1980271797 @default.
• W2912999289 cites W1983789568 @default.
• W2912999289 cites W1989392090 @default.
• W2912999289 cites W1989426152 @default.
• W2912999289 cites W1998551037 @default.
• W2912999289 cites W2024656127 @default.
• W2912999289 cites W2025763171 @default.
• W2912999289 cites W2026989650 @default.
• W2912999289 cites W2039012184 @default.
• W2912999289 cites W2041255666 @default.
• W2912999289 cites W2044475288 @default.
• W2912999289 cites W2045424644 @default.
• W2912999289 cites W2056995570 @default.
• W2912999289 cites W2060258953 @default.
• W2912999289 cites W2061955697 @default.
• W2912999289 cites W2077890234 @default.
• W2912999289 cites W2090485171 @default.
• W2912999289 cites W2114501722 @default.
• W2912999289 cites W2127919322 @default.
• W2912999289 cites W2132240217 @default.
• W2912999289 cites W2140501627 @default.
• W2912999289 cites W2150839822 @default.
• W2912999289 cites W2160678403 @default.
• W2912999289 cites W2163050713 @default.
• W2912999289 cites W2229685468 @default.
• W2912999289 cites W2300315891 @default.
• W2912999289 cites W2343000836 @default.
• W2912999289 cites W2547914787 @default.
• W2912999289 cites W2612534502 @default.
• W2912999289 cites W2767161259 @default.
• W2912999289 cites W826905404 @default.
• W2912999289 doi "https://doi.org/10.2147/ijn.s190426" @default.
• W2912999289 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6391151" @default.
• W2912999289 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30863054" @default.
• W2912999289 hasPublicationYear "2019" @default.
• W2912999289 type Work @default.
• W2912999289 sameAs 2912999289 @default.
• W2912999289 citedByCount "30" @default.
• W2912999289 countsByYear W29129992892019 @default.
• W2912999289 countsByYear W29129992892020 @default.
• W2912999289 countsByYear W29129992892021 @default.
• W2912999289 countsByYear W29129992892022 @default.
• W2912999289 countsByYear W29129992892023 @default.
• W2912999289 crossrefType "journal-article" @default.
• W2912999289 hasAuthorship W2912999289A5015663142 @default.
• W2912999289 hasAuthorship W2912999289A5031352775 @default.
• W2912999289 hasAuthorship W2912999289A5032300944 @default.
• W2912999289 hasAuthorship W2912999289A5059080514 @default.
• W2912999289 hasAuthorship W2912999289A5061082958 @default.
• W2912999289 hasAuthorship W2912999289A5061389332 @default.
• W2912999289 hasAuthorship W2912999289A5062026697 @default.
• W2912999289 hasAuthorship W2912999289A5062291767 @default.
• W2912999289 hasAuthorship W2912999289A5062825151 @default.
• W2912999289 hasAuthorship W2912999289A5063486241 @default.
• W2912999289 hasAuthorship W2912999289A5079206958 @default.
• W2912999289 hasBestOaLocation W29129992891 @default.
• W2912999289 hasConcept C112705442 @default.
• W2912999289 hasConcept C155574463 @default.
• W2912999289 hasConcept C171250308 @default.
• W2912999289 hasConcept C178790620 @default.
• W2912999289 hasConcept C181389837 @default.
• W2912999289 hasConcept C185592680 @default.
• W2912999289 hasConcept C192562407 @default.
• W2912999289 hasConcept C2779820397 @default.
• W2912999289 hasConcept C43617362 @default.
• W2912999289 hasConcept C71924100 @default.
• W2912999289 hasConcept C98274493 @default.
• W2912999289 hasConceptScore W2912999289C112705442 @default.
• W2912999289 hasConceptScore W2912999289C155574463 @default.
• W2912999289 hasConceptScore W2912999289C171250308 @default.
• W2912999289 hasConceptScore W2912999289C178790620 @default.
• W2912999289 hasConceptScore W2912999289C181389837 @default.
• W2912999289 hasConceptScore W2912999289C185592680 @default.
• W2912999289 hasConceptScore W2912999289C192562407 @default.
• W2912999289 hasConceptScore W2912999289C2779820397 @default.
• W2912999289 hasConceptScore W2912999289C43617362 @default.
• W2912999289 hasConceptScore W2912999289C71924100 @default.
• W2912999289 hasConceptScore W2912999289C98274493 @default.
• W2912999289 hasLocation W29129992891 @default.

• next